Studies in human populations identified an association of gene polymorphism in the Klf6 gene, KLF6-IVS1–27A, that attenuates Klf6 splicing with hepatic insulin resistance and delays NAFLD progression [54]. The gene discussed is KLF6; the disease is metabolic dysfunction-associated steatotic liver disease.